Tuesday, September 4, 2012
Baxter International Inc: $BAX Cash Flow Valuation Update
Current Price: ~ $59/share
Yield: ~ 2.24%
Baxter International focuses on delivering injectable therapies for a wide variety of medical conditions. The firm's BioScience segment specializes in developing treatments for disorders such as hemophilia and immune deficiencies. It also provides a variety of medication delivery systems including intravenous bags, solutions, and other devices to control fluid inflow, including dialysis equipment and solutions for patients with kidney failure.